Human embryonic stem cell–derived mesenchymal stem cells ameliorate mitochondrial oxidative dysfunction in metabolic dysfunction–associated steatotic liver disease
Abstract Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common chronic liver disease with significant clinical burden. This study investigated the therapeutic potential of embryonic stem cell-derived mesenchymal stem cells (ESC-MSCs) in cellular and murine models of MASLD. Methods He...